A polymorphic microsatellite repeat within the ECE-1c promoter is involved in transcriptional start site determination, human evolution, and Alzheimer's disease

Journal of Neuroscience

Volumn 32, Issue 47, 2012, Pages 16807-16820

  Li, Yaosi ^a   Seidel, Kerstin ^a   Marschall, Peter ^a   Klein, Michael ^a   Hope, Antonia ^a   Schacherl, Jens ^a   Schmitz, Jennifer ^a   Menk, Mario ^a   Schefe, Jan H ^a   Reinemund, Jana ^a   Hugel, Rebecca ^a   Walden, Peter ^a   Schlosser, Andreas ^b   Volkmer, Rudolf ^a   Schimkus, Julia ^a   Kölsch, Heike ^c   Maier, Wolfgang ^c   Kornhuber, Johannes ^d   Frölich, Lutz ^e   Klare, Sabrina ^a   Kirsch, Sebastian ^a   Schmerbach, Kristin ^a   Scheele, Sylvia ^a   Grittner, Ulrike ^a   Zollmann, Frank ^a   Goldin Lang, Petra ^a   Peters, Oliver ^a   Kintscher, Ulrich ^a   Unger, Thomas ^a   Funke Kaiser, Heiko ^a   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN CONVERTING ENZYME; GLUTAMINE; MESSENGER RNA; MICROSATELLITE DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PLACEBO; PROLINE; VALSARTAN;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA BASE COMPOSITION; EVOLUTION; FEMALE; GEL MOBILITY SHIFT ASSAY; GEL PERMEATION CHROMATOGRAPHY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE REPEAT; PAN TROGLODYTES; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION SITE; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BIOLOGICAL EVOLUTION; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, GEL; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENOTYPE; HUMANS; METALLOENDOPEPTIDASES; MICROSATELLITE REPEATS; NUCLEASE PROTECTION ASSAYS; PAN TROGLODYTES; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION, GENETIC;

EID: 84869996121     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2636-12.2012     Document Type: Article

References (67)

1. Ballestar E, Wolffe AP (2001) Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem 268:1-6. S
2. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9:768-778. CrossRef Medline
3. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368:387-403. CrossRef Medline
4. Butler JE, Kadonaga JT (2002) The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 16:2583-2592. CrossRef Medline
5. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engström PG, Frith MC, Forrest AR, Alkema WB, Tan SL, Plessy C, Kodzius R, Ravasi T, Kasukawa T, Fukuda S, Kanamori-Katayama M, Kitazume Y, et al. (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38:626-635. CrossRef Medline
6. Carty NC, Nash K, Lee D, Mercer M, Gottschall PE, Meyers C, Muzyczka N, Gordon MN, Morgan D (2008) Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP PS1 transgenic mice. Mol Ther 16:1580-1586. CrossRef Medline
7. Chimpanzee Sequencing and Analysis Consortium (2005) Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437:69-87. Medline
8. Choi DS, Wang D, Yu GQ, Zhu G, Kharazia VN, Paredes JP, Chang WS, Deitchman JK, Mucke L, Messing RO (2006) PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc Natl Acad Sci U S A 103:8215-8220. CrossRef Medline
9. D'Amours D, Desnoyers S, D'Silva I, Poirier GG (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249-268. CrossRef Medline
10. Davenport AP, Kuc RE, Plumpton C, Mockridge JW, Barker PJ, Huskisson NS (1998) Endothelin-converting enzyme in human tissues. Histochem J 30:359-374. CrossRef
11. Eckman EA, Reed DK, Eckman CB (2001) Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J Biol Chem 276: 24540-24548. CrossRef Medline
12. Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB (2003) Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278:2081-2084. CrossRef Medline
13. Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH, Xiao HD, Bernstein KE, Eckman CB (2006) Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelinconverting enzyme but not angiotensin-converting enzyme. J Biol Chem 281:30471-30478. CrossRef Medline
14. Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, Léonard N, Codron V, David JP, Amouyel P, Schwartz JC, Helbecque N (2004) Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Mol Psychiatry 9:1122-1128, 1059. Medline
15. Funke-Kaiser H, Bolbrinker J, Theis S, Lemmer J, Richter CM, Paul M, Orzechowski HD (2000) Characterization of the c-specific promoter of the gene encoding human endothelin-converting enzyme-1 (ECE-1). FEBS Lett 466:310-316. CrossRef Medline
16. Funke-Kaiser H, Theis S, Behrouzi T, Thomas A, Scheuch K, Zollmann FS, Paterka M, Paul M, Orzechowski HD (2001) Functional characterization of the human prion protein promoter in neuronal and endothelial cells. J Mol Med 79:529-535. CrossRef Medline
17. Funke-Kaiser H, Lemmer J, Langsdorff CV, Thomas A, Kovacevic SD, Strasdat M, Behrouzi T, Zollmann FS, Paul M, Orzechowski HD (2003a) Endothelin-converting enzyme-1 (ECE-1) is a downstream target of the homeobox transcription factor Nkx2-5. FASEB J 17:1487-1489. Medline
18. Funke-Kaiser H, Thomas A, Bremer J, Kovacevic SD, Scheuch K, Bolbrinker J, Theis S, Lemmer J, Zimmermann A, Zollmann FS, Herrmann SM, Paul M, Orzechowski HD (2003b) Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites. J Hypertens 21:2111-2124. CrossRef Medline
19. Funke-Kaiser H, Reichenberger F, Köpke K, Herrmann SM, Pfeifer J, Orzechowski HD, Zidek W, Paul M, Brand E (2003c) Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Hum Mol Genet 12:423-433. CrossRef Medline
20. Gatchel JR, Zoghbi HY (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6:743-755. CrossRef Medline
21. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63:168-174. CrossRef Medline
22. Gearing M, Rebeck GW, Hyman BT, Tigges J, Mirra SS (1994) Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A 91:9382-9386. CrossRef Medline
23. Gershenzon NI, Ioshikhes IP (2005) Synergy of human Pol II core promoter elements revealed by statistical sequence analysis. Bioinformatics 21: 1295-1300. CrossRef Medline
24. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314:777-781. CrossRef Medline
25. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41:1088-1093. CrossRef Medline
26. Heinemeyer T, Chen X, Karas H, Kel AE, Kel OV, Liebich I, Meinhardt T, Reuter I, Schacherer F, Wingender E (1999) Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Res 27:318-322. CrossRef Medline
27. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43:429-435. CrossRef Medline
28. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM (2001) Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 104:864-869. CrossRef Medline
29. Jagtap P, Szabó C (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421-440. CrossRef Medline
30. Khaitovich P, Hellmann I, Enard W, Nowick K, Leinweber M, Franz H, Weiss G, Lachmann M, Pääbo S (2005) Parallel patterns of evolution in the genomes and transcriptomes of humans and chimpanzees. Science 309: 1850-1854. CrossRef Medline
31. Kim MY, Zhang T, Kraus WL (2005) Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD into a nuclear signal. Genes Dev 19:1951-1967. CrossRef Medline
32. Kintscher U, Marx N, Martus P, Stoppelhaar M, Schimkus J, Schneider A, Walcher D, Kummel A, Winkler R, Kappert K, Dörffel Y, Scholze J, Unger T (2010) Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension. Diabetes Res Clin Pract 89:209-215. CrossRef Medline
33. Kornhuber J, Schmidtke K, Frolich L, Perneczky R, Wolf S, Hampel H, Jessen F, Heuser I, Peters O, Weih M, Jahn H, Luckhaus C, Hull M, Gertz HJ, Schröder J, Pantel J, Rienhoff O, Seuchter SA, Ruther E, Henn F, et al. (2009) Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord 27:404-417. CrossRef Medline
34. Kraus WL, Lis JT (2003) PARP goes transcription. Cell 113:677-683. CrossRef Medline
35. Li K, Dai D, Yao L, Gu X, Luan K, Tian W, Zhao Y, Wang B (2008) Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population. Neurosci Lett 433:125-128. CrossRef Medline
36. Lindenau S, von Langsdorff C, Saxena A, Paul M, Orzechowski HD (2006) Genomic organisation of the mouse gene encoding endothelinconverting enzyme-1 (ECE-1) and mRNA expression of ECE-1 isoforms in murine tissues. Gene 373:109-115. CrossRef Medline
37. Lindholm E, Hodge SE, Greenberg DA (2004) Comparative informativeness for linkage of multiple SNPs and single microsatellites. Hum Hered 58:164-170. CrossRef Medline
38. Love S, Barber R, Wilcock GK (1999) Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain 122:247-253. Medline
39. Meisterernst M, Stelzer G, Roeder RG (1997) Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro. Proc Natl Acad Sci USA 94:2261-2265. CrossRefMedline
40. Mulero JJ, Chang CW, Hennessy LK (2006) Characterization of the N 3 stutter product in the trinucleotide repeat locus DYS392. J Forensic Sci 51:1069-1073. CrossRef Medline
41. Murray V, Monchawin C, England PR (1993) The determination of the sequences present in the shadow bands of a dinucleotide repeat PCR. Nucleic Acids Res 21:2395-2398. CrossRef Medline
42. Oetjen J, Fives-Taylor P, Froeliger E (2001) Characterization of a streptococcal endopeptidase with homology to human endothelin-converting enzyme. Infect Immun 69:58-64. CrossRef Medline
43. Olejniczak M, Krzyzosiak WJ (2006) Genotyping of simple sequence repeats-factors implicated in shadow band generation revisited. Electrophoresis 27:3724-3734. CrossRef Medline
44. Olson MV, Varki A (2003) Sequencing the chimpanzee genome: insights into human evolution and disease. Nat Rev Genet 4:20-28. CrossRef Medline
45. Palmer J, Love S (2011) Endothelin receptor antagonists: potential in Alzheimer's disease. Pharmacol Res 63:525-531. Medline
46. Reinemund J, Seidel K, Steckelings UM, Zaade D, Klare S, Rompe F, Katerbaum M, Schacherl J, Li Y, Menk M, Schefe JH, Goldin-Lang P, Szabo C, Olah G, Unger T, Funke-Kaiser H (2009) Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochem Pharmacol 77:1795-1805. CrossRef Medline
47. Rich S, McLaughlin VV (2003) Endothelin receptor blockers in cardiovascular disease. Circulation 108:2184-2190. CrossRef Medline
48. Roberson ED, Mucke L (2006) 100 years and counting: prospects for defeating Alzheimer's disease. Science 314:781-784. CrossRef Medline
49. Roosterman D, Cottrell GS, Padilla BE, Muller L, Eckman CB, Bunnett NW, Steinhoff M (2007) Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling. Proc Natl Acad Sci USA 104:11838-11843. CrossRefMedline
50. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, Ruiz P, Unger T, Funke-Kaiser H (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99: 1355-1366. CrossRef Medline
51. Schweizer A, Valdenaire O, Nelböck P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Löffler BM (1997) Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 328:871-877. Medline
52. Seidel K, Kirsch S, Lucht K, Zaade D, Reinemund J, Schmitz J, Klare S, Li Y, Schefe JH, Schmerbach K, Goldin-Lang P, Zollmann FS, Thöne-Reineke C, Unger T, Funke-Kaiser H (2011) The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke. Brain Pathol 21:31-43. Medline
53. Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, Sani G, Modesti PA (2000) Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res 86:377-385. CrossRef Medline
54. Sharif J, Endo TA, Toyoda T, Koseki H (2010) Divergence of CpG island promoters: a consequence or cause of evolution? Dev Growth Differ 52: 545-554. CrossRef Medline
55. Shav-Tal Y, Zipori D (2002) PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett 531:109-114. CrossRef Medline
56. Slattery E, Dignam JD, Matsui T, Roeder RG (1983) Purification and analysis of a factor which suppresses nick-induced transcription by RNA polymerase II and its identity with poly(ADP-ribose) polymerase. J Biol Chem 258:5955-5959. Medline
57. Sluck JM, Lin RC, Katolik LI, Jeng AY, Lehmann JC (1999) Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience 91:1483-1497. CrossRef Medline
58. Smale ST (2001) Core promoters: active contributors to combinatorial gene regulation. Genes Dev 15:2503-2508. CrossRef Medline
59. Tanzi RE, Moir RD, Wagner SL (2004) Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 43:605-608. CrossRef Medline
60. Tapia-Páez I, Tammimies K, Massinen S, Roy AL, Kere J (2008) The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia. FASEB J 22:3001-3009. CrossRef Medline
61. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB (1999a) A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 264:341-349. CrossRef Medline
62. Valdenaire O, Barret A, Schweizer A, Rohrbacher E, Mongiat F, Pinet F, Corvol P, Tougard C (1999b) Two di-leucine-based motifs account for the different subcellular localizations of the human endothelinconverting enzyme (ECE-1) isoforms. J Cell Sci 18:3115-3125. Medline
63. Walsh PS, Fildes NJ, Reynolds R (1996) Sequence analysis and characterization of stutter products at the tetranucleotide repeat locus vWA. Nucleic Acids Res 24:2807-2812. CrossRef Medline
64. Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, de Wit D, Emoto N, Hammer RE (1998) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825-836. Medline
65. Zhang J, Leontovich A, Sarras MP Jr (2001) Molecular and functional evidence for early divergence of an endothelin-like system during metazoan evolution: analysis of the Cnidarian, hydra. Development 128:1607-1615. Medline
66. Ziegler M, Oei SL (2001) A cellular survival switch: poly(ADP-ribosyl)ation stimulates DNA repair and silences transcription. Bioessays 23:543-548. CrossRef Medline
67. Zlokovic BV (2008) New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 5:409-414. CrossRef Medline